Invention Grant
US09000014B2 Pyridonyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof
有权
吡咯烷酮胍F1F0-ATP酶抑制剂及其治疗用途
- Patent Title: Pyridonyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof
- Patent Title (中): 吡咯烷酮胍F1F0-ATP酶抑制剂及其治疗用途
-
Application No.: US13992254Application Date: 2011-12-08
-
Publication No.: US09000014B2Publication Date: 2015-04-07
- Inventor: Gary D. Glick , Alexander R. Hurd , Matthew N. Mattson , Clarke B. Taylor , Chad A. Van Huis
- Applicant: Gary D. Glick , Alexander R. Hurd , Matthew N. Mattson , Clarke B. Taylor , Chad A. Van Huis
- Applicant Address: US MI Ann Arbor
- Assignee: Lycera Corporation
- Current Assignee: Lycera Corporation
- Current Assignee Address: US MI Ann Arbor
- Agency: Goodwin Procter LLP
- International Application: PCT/US2011/063945 WO 20111208
- International Announcement: WO2012/078869 WO 20120614
- Main IPC: C07D213/75
- IPC: C07D213/75 ; A61K31/44 ; C07D213/76 ; C07D401/12 ; C07D405/12 ; C07D413/12
Abstract:
The invention provides pyridonyl guanidine compounds that inhibit F1F0-ATPase, and methods of using pyridonyl guanidine compounds as therapeutic agents to treat medical disorders, such as an immune disorder, inflammatory condition, or cancer.
Public/Granted literature
- US20140051727A1 PYRIDONYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF Public/Granted day:2014-02-20
Information query
IPC分类:
